CVC is in advanced talks to buy a controlling stake in the pharmaceutical business of Italy’s billionaire Recordati family, the Financial Times reported. A deal, valued at 3 billion euros ($3.5 billion), could be reached before the end of the month, the story said.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.